One Stop Solution for CAR Lead Generation

CAR-T cell terapy is one of the most promising cancer therapies in the recent few years. And the CAR fragment is the most imprtant part of a CAR-T cell to trigger the whole immuno therapy. In this webinar, the presenter will introduce the ProBio one-stop sloution for CAR lead discovery.

• Speaker: Alex Chen, Group Leader of Project Manager, Discovery Department, ProBio
• Date: Apr.6^th, 2021
• Time: 12:30-12:50PM UTC

Speaker Profile.

MS degree of biotechnology from Northeastern University Previous working experiments at GSK and Biogen. After joining GenScript, Alex is in charge of project evaluation and management of Antibody Drug Discovery and engineering services. He has more than 5 years’ experience in antibody discovery and successfully delivered more than hundreds of antibody related projects.

Related Services

ProCAR™ CAR Lead Discovery Service

ProBio provides integrated scFv or sdAb generation, optimization, CAR-encoding lentivirus packaging, CAR-T cell expression and in vitro functional validation services specially designed for CAR Lead Discovery.

So far, we have successfully delivered over 20 lead generation projects to CAR-T therapy companies. At the same time, ProBio has seamless downstream services, including plasmid and lentiviral vector process development and #GMP manufacturing.